Randomized, Placebo-Controlled Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Lecithin Cholesterol Acyltransferase in Acute ST-Segment-Elevation Myocardial Infarction: Results of REAL-TIMI 63B.
Marc P BonacaDavid A MorrowBrian A BergmarkDavid D BergJoao Augusto Costa LimaUdo HoffmannYoko KatoMichael T LuJulia KuderSabina A MurphyJindrich SpinarTon Oude OphuisRóbert G KissJose Luis Lopez SendonOleg AverkovStephen B WheatcroftJacek KubicaJose Carlos NicolauRemo Holanda de Mendonça FurtadoLiron AbuhatziraBoaz HirshbergSami A OmarAndrea L VavereYi-Ting ChangRichard T GeorgeMarc S SabatinePublished in: Circulation (2022)
gov; Unique identifier: NCT03578809.
Keyphrases
- st segment elevation myocardial infarction
- placebo controlled
- double blind
- recombinant human
- percutaneous coronary intervention
- phase iii
- phase ii
- liver failure
- clinical trial
- study protocol
- coronary artery disease
- respiratory failure
- randomized controlled trial
- acute coronary syndrome
- drug induced
- squamous cell carcinoma
- phase ii study
- radiation therapy
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome